ARCHIVES

NCI Program Review: Report calls For Two Types Of Centers: Comprehensive And All Others

This article is from The Cancer Letter archive.

Vol. 22 No. 40 | October 18, 1996

Download PDF Visit The Full Archive

Related Articles

FDA Approves Abraxane And Alimta for NSCLC

October 26, 2012

FDA Reaction to DCT Proposals ‘Positive,’ But Chabner, Wittes ‘Disappointed’ In That Response

June 17, 1988

Guest Editorial By ACS Chief Medical Officer Otis Brawley: ACS Revises Process for Making Guidelines

January 13, 2012

Concepts Approved For New Technology In Computers, Recompetition

November 6, 1987

Fourteen Immunology RFPs Announced, NCI will Have Eight More Immunodiagnosis; $43 Million Budgeted

September 6, 1974

Lung Cancer Prevention Diet Study Concept Tabled By DCPC Board

February 8, 1985